SCHEMBL5120927

SCHEMBL5120927

NCCN(Cc1ccc(OCc2ccccc2)c(Cl)c1)C(=O)Cc1ccc(F)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 3/20 0.47
PPARA Q07869 2/20 0.46
RAF1 P04049 2/20 0.45
MAP2K1 Q02750 2/20 0.45
HPGD P15428 3/20 0.43
MRGPRX4 Q96LA9 1/20 0.43
MC4R P32245 1/20 0.43
MC3R P41968 1/20 0.43
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
KMT2A Q03164 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
SLC1A5 Q15758 1/20 0.42
LTB4R Q15722 2/20 0.42
LTB4R2 Q9NPC1 2/20 0.42
RXRA P19793 1/20 0.42
RXRB P28702 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5122198 0.89 HPGD (0.54) TRPM8PPARARAF1MAP2K1HPGD
SCHEMBL14078359 0.87 TRPM8 (0.62) TRPM8RAF1MAP2K1HPGDMEN1
Hydrochloric Acid SCHEMBL5114617 0.86 TRPM8 (0.61) TRPM8RAF1MAP2K1HPGDMEN1
SCHEMBL5318308 0.85 TRPM8 (0.51) TRPM8PPARAMRGPRX4MEN1KMT2A
Hydrochloric Acid SCHEMBL5318361 0.85 TRPM8 (0.51) TRPM8PPARAMRGPRX4MEN1KMT2A
SCHEMBL14464542 0.82 TRPM8 (0.71) TRPM8PPARAHPGDMRGPRX4MEN1
Hydrochloric Acid SCHEMBL5338163 0.81 TRPM8 (0.70) TRPM8PPARAHPGDMRGPRX4MEN1
SCHEMBL14610607 0.79 TRPM8 (0.64) TRPM8RAF1MAP2K1HPGDMRGPRX4
SCHEMBL14610644 0.78 HPGD (0.51) PPARARAF1MAP2K1HPGDMRGPRX4
SCHEMBL14078281 0.78 TRPM8 (0.54) TRPM8RAF1MAP2K1MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080214654-A1 Substituted Benzyloxy-Phenylmethylamide Derivatives BAYER HEALTHCARE AG (DE) 2008-09-04 US disclosed
US-20080214654-A1 Substituted Benzyloxy-Phenylmethylamide Derivatives BAYER HEALTHCARE AG (DE) 2008-09-04 US disclosed
US-20080214654-A1 Substituted Benzyloxy-Phenylmethylamide Derivatives BAYER HEALTHCARE AG (DE) 2008-09-04 US disclosed
EP-1802600-A1 SUBSTITUTED 4-BENZYLOXY-PHENYLMETHYLAMIDE DERIVATIVES AS COLD MENTHOL RECEPTOR-1 (CMR-1) ANTAGONITS FOR THE TREATMENT OF UROLOGICAL DISORDERS Bayer HealthCare AG (DE) 2007-07-04 EP disclosed
WO-2006040136-A1 SUBSTITUTED 4-BENZYLOXY-PHENYLMETHYLAMIDE DERIVATIVES AS COLD MENTHOL RECEPTOR-1 (CMR-1) ANTAGONISTS FOR THE TREATMENT OF UROLOGICAL DISORDER BAYER HEALTHCARE AG (DE) 2006-04-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080214654-A1 Substituted Benzyloxy-Phenylmethylamide Derivatives OPRL1, ADRA1A, CNR1 TRPM8 124/4885PPARA 988/4885RAF1 4368/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.